Guardant Health (GH) Co-CEO logs RSU grants, tax withholding and trust share transfer
Rhea-AI Filing Summary
Guardant Health Co-CEO AmirAli Talasaz reported compensation-related equity activity and trust-related share movements. On March 17, 2026, he received awards of 11,268 and 101,409 restricted stock units that vest over quarterly and multi-year schedules. Earlier, on January 1 and March 13, 2026, performance-based and time-based RSUs covering 38,283 and 26,961 shares were exercised into common stock, with 19,402 and 13,664 shares withheld by the company to cover tax obligations. In connection with these events, 13,209 common shares were transferred from direct ownership into the Talasaz and Eskandari 2017 Family Trust, which held 2,128,489 shares after the March 13, 2026 transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 32,178 shares
Net Buy
10 txns
Insider
Talasaz AmirAli
Role
Co-Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 11,268 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 101,409 | $0.00 | $0.00 |
| Exercise | Performance-Based Restricted Stock Units | 26,961 | $0.00 | $0.00 |
| Exercise | Common Stock | 26,961 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 13,664 | $85.49 | $1.17M |
| Exercise | Restricted Stock Units | 38,283 | $0.00 | $0.00 |
| Other | Common Stock | 13,209 | $0.00 | $0.00 |
| Other | Common Stock | 13,209 | $0.00 | $0.00 |
| Exercise | Common Stock | 38,283 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 19,402 | $102.14 | $1.98M |
Holdings After Transaction:
Restricted Stock Units — 190,404 shares (Direct);
Performance-Based Restricted Stock Units — 0 shares (Direct);
Common Stock — 0 shares (Direct);
Common Stock — 2,128,489 shares (Indirect, Shares held by Talasaz and Eskandari 2017 Family Trust)
Footnotes (6)
- F1. Reflects changes in form of ownership from direct to indirect due to transfer of shares to Talasaz and Eskandari 2017 Family Trust.
- F2. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F3. This represents a restricted stock unit award granted on March 12, 2025 that vested with respect to 33% of the shares on January 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
- F4. Not applicable for Restricted Stock Units.
- F5. This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter, March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026.
- F6. This represents a restricted stock unit award granted on March 17, 2026 that vests over a three-year period. 33% of the shares subject to such award vests on January 1, 2027 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Guardant Health (GH) Co-CEO AmirAli Talasaz report in this Form 4?
He reported new restricted stock unit grants, vesting-related exercises, tax-withholding share dispositions, and a transfer of common shares into a family trust, reflecting compensation and ownership-structure updates rather than open-market buying or selling activity.
How many new restricted stock units did GH grant to AmirAli Talasaz?
He received two new restricted stock unit awards on March 17, 2026, covering 11,268 and 101,409 underlying shares of Guardant Health common stock, with vesting spread across quarterly dates and a three-year period, subject to continued service and applicable award terms.
What performance-based equity activity did AmirAli Talasaz report for Guardant Health (GH)?
He exercised 26,961 performance-based restricted stock units on March 13, 2026, converting them into an equal number of Guardant Health common shares held through the family trust, demonstrating settlement of previously granted performance-linked awards rather than new market purchases.